Cargando…

Characterization of 100 sequential SARS‐CoV‐2 convalescent plasma donations

BACKGROUND: Transfusion of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) convalescent plasma is a promising treatment for severe coronavirus disease 2019 (COVID‐19) cases, with success of the intervention based on neutralizing antibody content. Measurement by serologic correlates with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jungbauer, Christof, Weseslindtner, Lukas, Weidner, Lisa, Gänsdorfer, Simon, Farcet, Maria R., Gschaider‐Reichhart, Eva, Kreil, Thomas R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536978/ https://www.ncbi.nlm.nih.gov/pubmed/32978802 http://dx.doi.org/10.1111/trf.16119

Ejemplares similares

Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays
por: Weidner, Lisa, et al.
Publicado: (2020)

SARS-CoV-2 IgG Levels Allow Predicting the Optimal Time Span of Convalescent Plasma Donor Suitability
por: Laner-Plamberger, Sandra, et al.
Publicado: (2022)

Longitudinal analysis of SARS‐CoV‐2 antibodies in 8000 U.S. first‐time convalescent plasma donations
por: Karbiener, Michael, et al.
Publicado: (2021)

Neutralizing Antibodies against SARS-CoV-2 and HLA Class I and II Polymorphism
por: Weidner, Lisa, et al.
Publicado: (2021)

Omicron Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Immunoglobulin Preparations Manufactured From Plasma Collected in the United States and Europe( )
por: Farcet, Maria R, et al.
Publicado: (2022)

Rapidly Increasing Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected During the 2020 Pandemic( )
por: Farcet, Maria R, et al.
Publicado: (2021)

No SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected Before the 2020 Pandemic
por: Schwaiger, Julia, et al.
Publicado: (2020)

Plasma from post-COVID-19 and COVID-19-Vaccinated Donors Results in Highly Potent SARS-CoV-2 Neutralization by Intravenous Immunoglobulins
por: Karbiener, Michael, et al.
Publicado: (2021)

Donating convalescent plasma for COVID-19 patients
por: Black, Emily
Publicado: (2020)

Convalescent plasma trial shows no benefit
por: Brown, Matthew
Publicado: (2020)

Calibrated comparison of SARS-CoV-2 neutralizing antibody levels in response to protein-, mRNA-, and vector-based COVID-19 vaccines
por: Karbiener, Michael, et al.
Publicado: (2022)

Feasibility of identifying plasma donors with high measles neutralizing antibody concentrations for the use of producing a measles hyperimmune globulin for postexposure prophylaxis
por: Lackner, Cornelia, et al.
Publicado: (2022)

Sample Buffer Containing Guanidine-Hydrochloride Combines Biological Safety and RNA Preservation for SARS-CoV-2 Molecular Diagnostics
por: Weidner, Lisa, et al.
Publicado: (2022)

What is the optimal usage of coronavirus disease 2019 convalescent plasma donations?
por: Focosi, Daniele, et al.
Publicado: (2021)

Synthesis of “Nereid,” a new phenol‐free detergent to replace Triton X‐100 in virus inactivation
por: Farcet, Jean‐Baptiste, et al.
Publicado: (2020)

Absence of pathogenic viruses in COVID‐19 convalescent plasma
por: Kandathil, Abraham J., et al.
Publicado: (2022)

Temporal Analysis of Serial Donations Reveals Decrease in Neutralizing Capacity and Justifies Revised Qualifying Criteria for Coronavirus Disease 2019 Convalescent Plasma
por: Girardin, Roxie C, et al.
Publicado: (2021)

Trends of participants in convalescent plasma donation for COVID-19 in Japan as the pandemic evolved
por: Suzuki, Tetsuya, et al.
Publicado: (2023)

Convalescent plasma for covid19 – How long should a donor be excluded from donation?
por: Kutner, Jose M., et al.
Publicado: (2020)

Antibody‐enhanced hepatitis E virus nanofiltration during the manufacture of human immunoglobulin
por: Kapsch, Anna‐Maria, et al.
Publicado: (2020)

1126. Learner Driven Call Center to increase Convalescent Plasma Donation in COVID-19
por: Joyner, Nancy M, et al.
Publicado: (2020)

Convalescent blood plasma (CBP) donated by recovered COVID-19 patients – A comment
por: Lung, Th., et al.
Publicado: (2021)

A case of COVID-19 Convalescent Plasma Donation in Greece: Directed donation for compassionate use in the donor's critically ill father
por: Vlachogianni, Glykeria, et al.
Publicado: (2020)

Production of anti‐SARS‐CoV‐2 hyperimmune globulin from convalescent plasma
por: Vandeberg, Peter, et al.
Publicado: (2021)

Comprehensive Comparison of Seven SARS-CoV-2-Specific Surrogate Virus Neutralization and Anti-Spike IgG Antibody Assays Using a Live-Virus Neutralization Assay as a Reference
por: Graninger, Marianne, et al.
Publicado: (2023)

Neutralizing antibodies in convalescent patients
por: Uhl, Lion F. K., et al.
Publicado: (2020)

Detection of SARS‐CoV‐2‐independent immunoregulatory activity of COVID‐19 convalescent plasma
por: Brox, Regine, et al.
Publicado: (2021)

Evaluation of SARS‐CoV‐2 antibody titers and potency for convalescent plasma donation: a brief commentary
por: Wouters, Elise, et al.
Publicado: (2020)

Orthopox viruses and the safety margins of solvent‐detergent treated plasma‐derived medicinal products
por: Kindermann, Johanna, et al.
Publicado: (2022)

Convalescent plasma therapy for B-cell–depleted patients with protracted COVID-19
por: Hueso, Thomas, et al.
Publicado: (2020)

Lessons learned from the use of COVID-19 convalescent plasma at Kaiser Permanente
por: Tse, Kevin, et al.
Publicado: (2022)

Organizing the Donation of Convalescent Plasma for a Therapeutic Clinical Trial on Ebola Virus Disease: The Experience in Guinea
por: Delamou, Alexandre, et al.
Publicado: (2016)

Psychological assessment and lived experiences of recovered COVID-19 patients who presented for convalescent plasma donation
por: Maheshwari, A., et al.
Publicado: (2021)

Knowledge and Attitudes of Young Adults Towards Donation of COVID-19 Convalescent Plasma and Its Therapeutic Properties
por: Perenc, Lidia, et al.
Publicado: (2021)

Use of Early Donated COVID-19 Convalescent Plasma Is Optimal to Preserve the Integrity of Lymphatic Endothelial Cells
por: Amri, Nada, et al.
Publicado: (2022)

Early Administration of Convalescent Plasma Improves Survival in Patients with Hematological Malignancies and COVID-19
por: Biernat, Monika Maria, et al.
Publicado: (2021)

Function matters: Coronavirus cross-binding antibodies do not cross-neutralize
por: Farcet, Maria R., et al.
Publicado: (2022)

Correlation between ABO blood group and neutralizing anti-SARS-CoV-2 antibody titers in convalescent plasma donations
por: Franchini, M., et al.
Publicado: (2022)

Comparison of SARS‐CoV‐2 neutralizing antibody testing of convalescent plasma donations in the Netherlands and England: A pilot study
por: Harvala, Heli, et al.
Publicado: (2021)

Lateral ST-elevation myocardial infarction after donation of COVID-19 convalescent plasma in a naïve donor
por: Shams, Pirbhat, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f8gapshpmlfj30d1kgdukc1kgr